HRPC - redOrbit

News - HRPC

Poniard Announces Positive First-Line Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in Patients With Metastatic Hormone Refractory Prostate Cancer

2008-05-31 09:00:07

SOUTH SAN FRANCISCO, Calif. and CHICAGO, May 31 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc.

Poniard Pharmaceuticals Announces Promising Data From Interim Safety Analysis of Phase 1 Combination Trials of Picoplatin in Colorectal and Prostate Cancers

2007-06-01 15:00:09

SOUTH SAN FRANCISCO, Calif., June 1 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc.

More News (2 articles) »